Defining Neurobiological Subtypes of Motor Functional Neurological Disorder
定义运动功能性神经疾病的神经生物学亚型
基本信息
- 批准号:10608983
- 负责人:
- 金额:$ 73.11万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-04-01 至 2026-03-31
- 项目状态:未结题
- 来源:
- 关键词:AftercareAmygdaloid structureAnteriorAnxiety DisordersApplications GrantsArchitectureBiological MarkersBrain imagingBrain scanCaringChild AbuseChildhoodClinicClinicalCognitive TherapyComplexConversion disorderCouplingDSM-VDataDevelopmentDiagnostic SpecificityDiagnostics ResearchDiffusion Magnetic Resonance ImagingDiseaseDisease MarkerDorsalEnrollmentEpidemicEtiologyEvidence based treatmentExhibitsFunctional ImagingFunctional Magnetic Resonance ImagingFunctional disorderFundingHeadacheHealth Care CostsHealthcareHeightHigh PrevalenceIndividualIndividual DifferencesInsula of ReilLife ExperienceLinkMRI ScansMagnetic Resonance ImagingMedicalMedicineModelingMoodsMotorMotor CortexMultimodal ImagingNational Institute of Mental HealthNeurobiologyNeurologistNeuronal PlasticityNeurosciencesOutcomeOutpatientsPatient ParticipationPatientsPerformancePhenotypePhysical therapyPopulationPrevalencePrognosisPrognostic MarkerPropertyPsychiatryRehabilitation therapyReportingResearchRestRetinal blind spotRisk FactorsSelection for TreatmentsSeveritiesSexual abuseSymptomsSystemTremorWorkbiopsychosocialblood oxygen level dependentcare outcomesdiagnostic criteriadisorder subtypefollow-upfunctional MRI scangraph theorygray matterimaging propertiesimaging studyimprovedinterestmagnetic resonance imaging biomarkermedian forebrain bundlemidbrain central gray substancemind controlmorphometrymotor behaviormotor controlmotor symptommultimodal neuroimagingmultimodalityneglectnervous system disorderneuralneural circuitneuroimagingneuromechanismneuropsychiatric disorderneuropsychiatrynovel therapeuticspatient prognosisphysical abusepredictive markerpsychologicrecruitresponsestria terminalisstructural imagingtheoriestreatment responsewhite matter
项目摘要
Project Summary / Abstract
Motor functional neurological disorder (mFND), also known as conversion disorder, is a common and
disabling neuropsychiatric condition whereby individuals present with psychogenic (medically-unexplained)
motor symptoms. mFND is amongst the most common conditions seen by neurologists and neuropsychiatrists
(2nd only to headache), and $256 billion is spent annually in healthcare costs for functional disorders. Despite
the high prevalence and healthcare expense, mFND has been largely neglected by the clinical neurosciences.
Over the past decade, significant renewed interest has been catalyzed by the revised DSM-5 diagnostic criteria
emphasizing physical exam signs specific for mFND and a growing repertoire of evidence-based treatments
(e.g., cognitive behavioral therapy, physical therapy). Many patients present with mixed symptoms and others
initially exhibiting one symptom complex (e.g., tremor) can later develop distinct symptoms (e.g., weakness)
over the course of their illness; this emphasizes the need for a transdiagnostic research approach across the
motor spectrum of FND. In parallel, convergent structural and functional magnetic resonance imaging (MRI)
findings have started defining the pathophysiology of mFND, characterizing alterations within and across
salience, multimodal integration and motor control networks. Within the biopsychosocial model, adverse early-
life experiences, particularly childhood abuse, are important risk factors for developing mFND. Research in
mFND has identified that childhood abuse burden is linked to increased symptom severity, poor prognosis,
reduced insula grey matter volume, and corticolimbic functional architectural changes. Specifically, individual
differences in childhood physical abuse burden correlate with motor cortex–amygdala and motor cortex–insula
functional connectivity strength properties. These findings represent biomarkers of heighted limbic influence
over motor behavior, highlighting the importance of childhood abuse as an etiological factor.
Building upon our prior NIMH funded research, this R01 grant proposal aims to perform multimodal
neuroimaging studies, with a longitudinal component, to neurobiologically define mFND subtypes. We also
seek to replicate our work and further characterize biomarkers predicting treatment response to standard
medical care (SMC). Aim 1 characterizes the neural signatures a high symptom severity mFND subtype, while
Aim 2 identifies the neural signatures a high childhood physical abuse mFND subtype. Aim 3 investigates how
baseline neural circuit properties relate to 6-month SMC outcomes, in addition to obtaining 6-month follow-up
MRI scans to study neural mechanisms of treatment response. These aims will be performed using
quantitative grey matter volumetry, resting-state functional MRI and diffusion tensor imaging, with the latter two
approaches leveraging graph theory. The long-term objectives of this research are to identify neurobiological
mFND subtypes that will guide prognosis and treatment selection, as well as aid the development of new
therapeutics through an improved pathophysiological understanding of this disabling neuropsychiatric disorder.
项目摘要/摘要
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
David Lewis Perez其他文献
David Lewis Perez的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('David Lewis Perez', 18)}}的其他基金
Defining Neurobiological Subtypes of Motor Functional Neurological Disorder
定义运动功能性神经疾病的神经生物学亚型
- 批准号:
10172117 - 财政年份:2021
- 资助金额:
$ 73.11万 - 项目类别:
Defining Neurobiological Subtypes of Motor Functional Neurological Disorder
定义运动功能性神经疾病的神经生物学亚型
- 批准号:
10378665 - 财政年份:2021
- 资助金额:
$ 73.11万 - 项目类别:
Neuroimaging Biomarkers of Symptom Severity, Adverse Life Events and Prognosis in Motor Functional Neurological Disorders
运动功能性神经疾病症状严重程度、不良生活事件和预后的神经影像生物标志物
- 批准号:
9769143 - 财政年份:2017
- 资助金额:
$ 73.11万 - 项目类别:
Neuroimaging Biomarkers of Symptom Severity, Adverse Life Events and Prognosis in Motor Functional Neurological Disorders
运动功能性神经疾病症状严重程度、不良生活事件和预后的神经影像生物标志物
- 批准号:
9451009 - 财政年份:2017
- 资助金额:
$ 73.11万 - 项目类别:
Neuroimaging Biomarkers of Symptom Severity, Adverse Life Events and Prognosis in Motor Functional Neurological Disorders
运动功能性神经疾病症状严重程度、不良生活事件和预后的神经影像生物标志物
- 批准号:
10218015 - 财政年份:2017
- 资助金额:
$ 73.11万 - 项目类别: